Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

Pharmacol Res. 2020 Oct:160:105055. doi: 10.1016/j.phrs.2020.105055. Epub 2020 Jun 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Edaravone
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome*

Substances

  • Edaravone